These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30586300)

  • 1. Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets.
    Zhou Y; Cahya S; Combs SA; Nicolaou CA; Wang J; Desai PV; Shen J
    J Chem Inf Model; 2019 Mar; 59(3):1005-1016. PubMed ID: 30586300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks.
    Ghasemi F; Mehridehnavi A; Pérez-Garrido A; Pérez-Sánchez H
    Drug Discov Today; 2018 Oct; 23(10):1784-1790. PubMed ID: 29936244
    [No Abstract]   [Full Text] [Related]  

  • 4. A Deep Learning-Based Chemical System for QSAR Prediction.
    Hu S; Chen P; Gu P; Wang B
    IEEE J Biomed Health Inform; 2020 Oct; 24(10):3020-3028. PubMed ID: 32142459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets.
    Korotcov A; Tkachenko V; Russo DP; Ekins S
    Mol Pharm; 2017 Dec; 14(12):4462-4475. PubMed ID: 29096442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imputation of Assay Bioactivity Data Using Deep Learning.
    Whitehead TM; Irwin BWJ; Hunt P; Segall MD; Conduit GJ
    J Chem Inf Model; 2019 Mar; 59(3):1197-1204. PubMed ID: 30753070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction.
    Liu K; Sun X; Jia L; Ma J; Xing H; Wu J; Gao H; Sun Y; Boulnois F; Fan J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A renaissance of neural networks in drug discovery.
    Baskin II; Winkler D; Tetko IV
    Expert Opin Drug Discov; 2016 Aug; 11(8):785-95. PubMed ID: 27295548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying Multitask Deep Neural Networks for Quantitative Structure-Activity Relationships.
    Xu Y; Ma J; Liaw A; Sheridan RP; Svetnik V
    J Chem Inf Model; 2017 Oct; 57(10):2490-2504. PubMed ID: 28872869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting Deep Learning QSPR Models to Specific Drug Discovery Projects.
    Fluetsch A; Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2024 Apr; 21(4):1817-1826. PubMed ID: 38373038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Neural Networks for QSAR.
    Xu Y
    Methods Mol Biol; 2022; 2390():233-260. PubMed ID: 34731472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR.
    Winkler DA; Le TC
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27783464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective.
    Fang C; Wang Y; Grater R; Kapadnis S; Black C; Trapa P; Sciabola S
    J Chem Inf Model; 2023 Jun; 63(11):3263-3274. PubMed ID: 37216672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
    Clark AM; Dole K; Coulon-Spektor A; McNutt A; Grass G; Freundlich JS; Reynolds RC; Ekins S
    J Chem Inf Model; 2015 Jun; 55(6):1231-45. PubMed ID: 25994950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
    Liu R; Schyman P; Wallqvist A
    J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaussian processes: a method for automatic QSAR modeling of ADME properties.
    Obrezanova O; Csanyi G; Gola JM; Segall MD
    J Chem Inf Model; 2007; 47(5):1847-57. PubMed ID: 17602549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of machine learning and nonlinear statistical tools for ADME prediction.
    Sakiyama Y
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):149-69. PubMed ID: 19239395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.